Related Experiment Video
Updated: May 11, 2026

Isolated Pancreatic Islet Treatment and Apoptosis Measurement
Published on: May 2, 2025
PAK1 limits the expression of the pro-apoptotic protein Bad in pancreatic islet β-cells
Zhanxiang Wang1, Debbie C Thurmond
1Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN 46202, United States.
Abstract:
Human type 2 diabetes is associated with β-cell apoptosis, and human islets from diabetic donors are ∼80% deficient in PAK1 protein. Toward addressing linkage of PAK1 to β-cell survival, PAK1-siRNA targeted MIN6 pancreatic β-cells were found to exhibit increased caspase-3 cleavage, cytosolic cytochrome-C and the pro-apoptotic protein Bad. PAK1(+/-) heterozygous mouse islets recapitulated the upregulation of Bad protein expression, as did hyperglycemic treatment of human or mouse islets; Bad levels were exacerbated most in PAK1(+/-) islets subjected to hyperglycemic stress. These data implicate PAK1 in β-cell survival via quenching of Bad protein expression, and suggest PAK1 as potential molecular target to preserve β-cell mass.
Insights
The study reveals that PAK1 protein deficiency in human type 2 diabetes contributes to beta-cell death by increasing the pro-apoptotic protein Bad. Restoring PAK1 may preserve beta-cell mass.
Area of Science:
- Endocrinology
- Molecular Biology
- Diabetes Research
Background:
- Type 2 diabetes is linked to beta-cell apoptosis.
- Human islets from diabetic donors show a significant reduction in PAK1 protein levels (approximately 80%).
Purpose of the Study:
- To investigate the role of PAK1 protein in the survival of pancreatic beta-cells.
- To explore the molecular mechanisms connecting PAK1 deficiency to beta-cell apoptosis.
Main Methods:
- Utilized PAK1-siRNA to target MIN6 pancreatic beta-cells.
- Examined protein expression levels of caspase-3, cytochrome-C, and Bad in treated cells and mouse islets.
- Assessed the impact of hyperglycemic conditions on PAK1(+/-) heterozygous mouse islets and human islets.
Main Results:
- PAK1-siRNA treated MIN6 cells showed increased caspase-3 cleavage and cytosolic cytochrome-C, indicating apoptosis.
- PAK1(+/-) heterozygous mouse islets exhibited elevated Bad protein expression.
- Hyperglycemic stress exacerbated Bad protein levels, particularly in PAK1(+/-) islets.
Conclusions:
- PAK1 plays a crucial role in beta-cell survival by suppressing the expression of the pro-apoptotic protein Bad.
- PAK1 deficiency contributes to beta-cell loss in type 2 diabetes.
- PAK1 represents a potential therapeutic target for preserving beta-cell mass.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
08:40Visualization of Endogenous Mitophagy Complexes In Situ in Human Pancreatic Beta Cells Utilizing Proximity Ligation Assay
Published on: May 2, 2019
Related Concept Videos
The Intrinsic Apoptotic Pathway
The JAK-STAT Signaling Pathway
Cell Specific Gene Expression
The Extrinsic Apoptotic Pathway
Caspases
PI3K/mTOR/AKT Signaling Pathway